The human hematopoietic stem cell compartment is comprised of repopulating CD34 + and CD34 À cells. The interaction between these subsets with respect to their reconstitution capacity in vivo remains to be characterized. 
The human hematopoietic stem cell compartment is comprised of repopulating CD34 + and CD34 À cells. The interaction between these subsets with respect to their reconstitution capacity in vivo remains to be characterized. Here, lineagedepleted (Lin À ) human CD34 + and CD34 À hematopoietic cells were isolated from human male and female umbilical cord blood (CB) and transplanted into immune-deficient NOD/SCID EMV null mice, thereby allowing the use of human and Ychromosome-specific DNA sequences to discriminate human reconstitution contributed by CD34 + vs CD34 À repopulating stem cells. Although cultured human CB CD34 
Introduction
Bone marrow (BM) cells enriched for cells expressing CD34 are capable of long-term multilineage hematopoietic reconstitution, 1, 2 and have been the primary focus of clinical transplantation. 3, 4 Transplantation of human CD34 + cells into immune-deficient mice or fetal sheep has provided a manner to further define the nature of human hematopoietic cells with repopulating capacity in vivo. [5] [6] [7] Recent findings in a variety of mammalian species suggest that the hematopoietic stem cell (HSC) compartment is comprised of a heterogeneous array of CD34 + and CD34 À cells that both exhibit repopulating function. [8] [9] [10] [11] [12] Primitive CD34 À HSCs were first described in the mouse by Osawa et al, 11 where transplantation of a single Lin À , CD34 À , Sca-1 + , c-kit + cell provided long-term multilineage reconstitution in lethally irradiated congenic mice. Additional studies demonstrated that rapid proliferation of transplanted murine CD34
À Lin À cells required the supportive role of CD34 + Lin À cells. 13 An immediate relation between these cellular subtypes was suggested by the reversible expression of CD34 in murine hematopoietic reconstituting cells harvested from 5-fluorouraciltreated mice. 14, 15 Initial evidence for primitive CD34
À cells capable of in vivo repopulating activity in the human arose from in vivo xenotransplantation studies for human repopulating function using the immune-deficient NOD/SCID mouse, 8 and preimmune fetal sheep recipient. 12 Dick's group demonstrated that multilineage engraftment of NOD/SCID mice could be achieved by transplantation of highly purified human CD34
À Lin À cells. 8 However, engrafting CD34 À Lin À cells were rare, and the levels of engraftment were lower than those obtained by transplanting equivalent numbers of CD34 + Lin À cells. 5, 8 Transplantation of primitive human CD34
À cells into fetal sheep demonstrated that the CD34
À fraction of human BM contains cells capable of longterm (41 year) reconstitution in primary and secondary hosts. 12 Although these initial studies suggested a developmental association between human CD34
À and CD34 + cells that is supported by previous murine studies using analogous subsets, 14 ,15 the absence of appropriate assays to examine the in vivo functional relation between CD34 + and CD34 À repopulating cells in the same recipient has limited our understanding of how these cells interact and contribute to hematopoietic reconstitution.
Here, coculture and transplantation of human-male-derived CD34
À Lin À and human-female-derived CD34 + Lin À populations in single murine recipients, followed by subsequent analysis of human Y-chromosome-specific sequences restricted to male engrafting cells, allowed in vivo tracking of human reconstitution arising from prospectively isolated stem cell populations. Using the NOD/SCID ecotropic murine virus-knockout (EMV null ) murine recipients, 16, 17 
Materials and methods

Human cells
Male and female human CB was obtained from full-term umbilical tissue in conjunction with local ethical and biohazard authorities at the University of Western Ontario and London Health Sciences Center. CB mononuclear cells (MNCs) were collected by centrifugation on Ficoll-Paque (Amersham-Pharmacia, Piscataway, NJ, USA).
Cell purification
CD34
À Lin À , CD34 + Lin À or CD34 + CD38 À Lin À cells were isolated using a standard protocol. 8, 18 Briefly, MNCs were enriched for lineage marker-depleted (Lin À ) cells by incubation with a cocktail of nine lineage-specific antibodies (CD2, CD3,  CD7, CD14, CD16, CD19, CD24, 
Lin
À and CD34 + Lin À cells were cultured as purified populations or were cocultured together for 4 days in serum-free liquid suspension culture using parameters previously established to support the survival of primitive cells and promote the engraftment of CD34
À Lin À populations in the NOD/SCID mouse. 8 Serum-free cultures contained bovine serum albumin, insulin, transferrin media (Stem Cell Technologies) supplemented with 10 À4 M b-mercaptoethanol, 2 mM L-glutamine (Gibco BRL) in combination with 300 ng/ml rhu-SCF, 50 ng/ml rhu-G-SCF (Amgen, Thousand Oaks, CA, USA), 300 ng/ml rhu-Flt-3, 10 ng/ml rhu-IL-3 and 10 ng/ml rhu-IL-6 (R&D Systems, Minneapolis, MN, USA). Cells were cultured in fibronectin-coated 96-well plates, harvested after 4 days, tested for viability by trypan blue dye exclusion and enumerated for transplantation.
Transplant of human cells
Cultured human cells were transplanted by tail vein injection into sublethally irradiated (350-375 cGy), 8 to 10-week-old NOD/SCID EMV null mice (Jackson Laboratories, Bar Harbor, MA, USA) according to standard protocols. 8 Mice were maintained under sterile conditions in microisolator cages in ventilated racks and BM cells were harvested from the femurs, tibiae and iliac crests 6-8 weeks post-transplant. 
Flow cytometric analysis of murine BM
CD38
+ cells were purified from mouse BM using a FACS Vantage SE (BD) and assayed for human clonogenic capacity described below.
Analysis of human and human-male cell engraftment DNA was extracted from BM cells of transplanted mice, digested with EcoR1, separated on agarose gels, and transferred to Hybond-N + nylon membrane (Amersham-Pharmacia) using standard molecular protocols. Southern blots were hybridized using a human chromosome 17-specific a-satellite probe (P17H8) described previously. 18 Human engraftment was quantified by comparison of the characteristic 2.7 kb band with human: mouse DNA mixture controls demonstrating linear band intensities by phosphoimaging (limit of detection, approximately 0.1% human DNA). The presence or absence of human DNA was confirmed by PCR (Gene Amp s PCR System 9700, PerkinElmer, Norwalk, CT, USA) for an untranslated region of the human-specific CART-1 gene as shown previously. 19 The criterion for human engraftment was the presence of 40.1% human DNA in the BM of transplanted mice by Southern blot and a positive CART-1 PCR. Analysis of human-male cell contribution too was determined by Southern blot and PCR for the human Y-chromosome-specific sequence DYS14. 20, 21 The Y-chromosome probe was synthesized by amplification of a 1.4 kb fragment (primers, Y1 5 0 -CCCACAATTCCAAAGACCAC-3 0 and Y2 5 0 -TGAGATCCCTGCTGTTGCTT-3 0 ). The resulting DNA fragment was cloned and digested with bgl1 to create a 960 bp fragment used for probe synthesis. The criterion for human engraftment from male sources was a recipient mouse demonstrating CART-1 and DYS14 PCR amplification product (performed in duplicate). The contribution to human graft chimerism by distinct cell populations was determined by the quantification of male engraftment in relation to overall human engraftment of murine BM by Southern blot analysis. (Stem Cell Technologies) containing 50 ng/ml rhu-SCF, 10 ng/ml rhu-GM-CSF (Amgen), 10 ng/ml rhu-IL-3, and 3 U/ml rhuerythropoietin (R&D Systems). Colonies were enumerated following incubation for 10-14 days, individual colonies were isolated from methylcellulose and DNA was extracted using phenol/chloroform isoamyl alcohol for CART-1 and DYS14 PCR analysis as described above.
Clonogenic progenitor assays
Statistics
Levels of human engraftment were shown as the mean7 standard error of the mean (s.e.m.) for mice grouped according to transplanted cell numbers. The frequency of SRC was determined by limiting dilution analysis as described previously. 5, 22 Statistical analysis of CFU data (frequency of colonies7s.e.m.) was performed by a two-tailed Student's t-test. 5, 8 We aimed to explore the functional relation between these cell types by transplant of purified populations of male and female CB cells into NOD/SCID EMV null mice. Accordingly, we first performed a side-by-side comparison of human CB multilineage reconstitution in the NOD/SCID and the NOD/SCID EMV null mouse (Figure 1 ), to ensure that equivalent human engraftment quality could be detected. BM samples from both strains were gated for human cells expressing the panleukocyte cell surface marker CD45 (Figure 1a (i) and b(i)) and displayed multilineage engraftment with similar representation of human B-cells (ii), myeloid cells (iii) and primitive CD34 + cells (iv). The T-cell lineage was not represented in either mouse (data not shown) due to the inability to support human T-cell maturation by the NOD/SCID host. 23 Our findings confirm that the NOD/SCID EMV null recipient mouse supports the differentiation of human repopulating cells similar to the parent NOD/SCID strain. 18 CB MNCs (10-30 Â 10 6 ) and purified CD34 + CD38 À Lin À cells (7-40 Â 10 3 ) enriched for SRC function 5 were also analyzed for human engraftment in both mouse strains (Figure 1c ). Comparison of each mouse strain indicated equal frequency (90-100%) and levels of engraftment were observed between the NOD/ SCID (16.673.3%) and the NOD/SCID EMV null recipient (16.876.4%). These comparisons indicated nearly identical multilineage engrafting characteristics in both mouse strains, yet the EMV null strain exhibited a reduced incidence of thymic lymphomas at 20-25 weeks of age. 24 Based on these characteristics, the NOD/SCID EMV null mouse was chosen to analyze CD34 neg -SRC function in vivo.
Results
NOD
Detection of mixed human chimerism in mice cotransplanted with human-male and human-female SRC Studies in both mouse and human have suggested that HSCs are heterogeneous, and include a variety of cells with a distinct function and regulation in vivo. 8, 10, 11 In order to define the nature of these cells and characterize the potential relation between human cells that possess repopulating potential, 
Cotransplant of CD34
+ and CD34 À stem cells DA Hess et al primitive subsets must be prospectively isolated, and their relative contribution to hematopoietic reconstitution tracked in vivo. To establish a model for accurate cell tracking of potentially repopulating cells from two distinct donors, de novo isolated human cells from male and female CB were cotransplanted into individual NOD/SCID EMV null mice and the relative contribution to human chimerism derived from 'male SRC' compared to 'female SRC' were quantitated ( Figure 2 ). Ychromosome and human Southern blot analysis for animals cotransplanted with male and female CB MNCs are shown in Figure 2a and b. PCR for Y-chromosome (DYS14) and human (CART-1) sequences from identical mice (Figure 2c and d) confirmed the Southern blot results. PCR was also a nonquantitative means to detect contribution from cells with repopulating capacity below the limit of detection by Southern blot.
To quantify the contribution to repopulation by individual (male or female) SRC during hematopoietic reconstitution, human CB MNCs or purified CD34 + CD38 À Lin À cells of male and female origin were cotransplanted into individual NOD/ SCID EMV null mice at doses that represent approximately 10-70 SRC, 5 and routinely achieve human hematopoietic repopulation. A summary of human vs male chimerism in the BM of cotransplanted mice is shown in Figure 2e . This analysis demonstrated that cotransplanted donor MNCs or purified cells (CD34 +
CD38
À Lin À ) from male and female sources can coexist and corepopulate the recipient mouse. As indicated in Figure 2e , male or female repopulation linearly correlated to the proportion of male and female repopulating cells cotransplanted. For example, mice transplanted with equal numbers of male and female cells demonstrate male cell contribution to overall human repopulation, which was approximately 55%. Taken together, these data demonstrate that the detection of engraftment from SRCs can be quantitatively subdivided into contributions from human-male and human-female cells in a single recipient, therefore providing a novel method to track the reconstituting function of two distinct human repopulating stem cells in vivo. This method would be applicable to the evaluation of subsets isolated using a variety of markers (CD34, CD38, AC133 etc) for direct in vivo comparison of competitive repopulating function.
De novo isolated CD34
À
Lin
À cells do not contribute to human repopulation when cotransplanted with CD34 + Lin À cells
Initial characterization of the CD34 neg -SRC revealed that high doses of transplanted CD34
À Lin À cells (450 000 de novo isolated cells) were required to observe engraftment of NOD/ SCID mice, 8 whereas equivalent doses of CD34 + Lin + cells produced robust repopulation in the same model. 5 Therefore, we first used the male/female cell cotransplant system to determine if the cotransplant of de novo isolated CD34
À Lin À cells with CD34 + Lin À cells would enhance the repopulating ability of CD34 neg SRC in vivo. Lineage-depleted cells were selected for viability using 7-AAD dye exclusion (gated R1) and forward and side scatter properties (gated R2, Figure 3a , inset). These cells were further separated according to the presence (gated R4) or absence (gated R3) of CD34 expression using FACS (Figure 3b) The frequency of detectable repopulation from CD34 À Lin À cells can be increased after short-term liquid culture. 8, 24 In order to directly compare the proliferation and differentiation of purified CD34
À Lin À and CD34 + Lin À cells during 4 days serum-free culture, CD34 + Lin À and CD34 À Lin À cells were cultured individually or cocultured together and analyzed for the potential expression of hematopoietic (CD45) and mature lineage markers (B-lymphocytes (CD19), T-lymphocytes (CD3), monocytes/macrophages (CD14), NK-cells (CD16)). Prior to culture, human CB lineage-depleted cells expressed CD45 but were devoid of the mature surface markers tested (Figure 5a-d Detection of mixed human chimerism in NOD/SCID EMV null mice cotransplanted with de novo isolated human-male and humanfemale cells. Representative Southern blot analysis for (a) Y-chromosome-specific sequences (limit of detection ¼ 1% human) or (b) human chromosome 17-specific a-satellite sequences (P17H8) (limit of detection ¼ 0.1% human) determined in mice transplanted with a total of 10 Â À Lin À cells during ex vivo culture in the absence of primitive supportive cell populations. 8, 25 In order to compare the repopulating capacity of purified CD34
À Lin À and CD34 + Lin À cells after 4-day ex vivo culture, these populations were cultured individually under identical serum-free conditions and transplanted at equivalent doses into NOD/SCID EMV null recipients (Figure 6a(i) ). 8, 18 As described previously for de novo isolated cells, the representative CART-1 and DYS 14 PCR demonstrated that human repopulation by CD34
À Lin À cells cultured alone was rarely detected by CART-1 PCR (Figure 6a(ii), lanes 1 and 2) , whereas cultured CD34 + Lin À cells readily gave rise to human chimerism (Figure 6a (ii), lanes 3 and 4). Figure 6a( (Figure 6b(i) ). Coculture and transplantation of both cell populations resulted in comparatively high overall human repopulation (48.676.1). As illustrated in the representative PCR, detection of male-specific sequences was demonstrated at cell doses of CD34 À Lin À cells unable to elicit consistent reconstitution on their own (Figure 6b (ii), lanes 5 and 6, 20 000 CD34 À Lin À with 20 000 CD34 + Lin À , lane 9, 60 000 CD34 À Lin À with 60 000 CD34 + Lin À ), and CD34 À Lin À cell progeny consistently contributed to repopulation only after coculture with CD34 + Lin À cells (Figure 4a (ii) and b(ii), lanes 1 and 2 vs lanes 5-9). While the contribution of CD34 À Lin À cells to the overall level human engraftment was still relatively minor (o 1%) compared to the repopulation from the CD34 + Lin À population, male-specific sequences were detected in four of the five human engrafted mice (Figure 6b(iii) ). Therefore, male CD34 À Lin À cells (CD34 neg -SRC) contributed to repopulation in 80% of the recipients only when transplanted after coculture with CD34 + Lin À cells. This can also be compared to a frequency of 15% when equivalent numbers of cultured CD34
À Lin À cells were transplanted alone (Figure 6a(iii) ). In similar control experiments, coculture and transplantation of male and female CD34 + Lin À cells from two independent human donors did not result in increased overall human engraftment ( (Figure 7) , analysis of human CFU isolated from repopulated mouse BM allowed for the quantitation of hematopoietic progenitors derived from male CD34 neg -SRC using DYS 14 PCR of single colonies. Human hematopoietic cells were isolated by FACS using the human-specific panleukocyte marker CD45 (Figure 7b(i) , gate R1), and purified based on CD34 and CD38 expression (Figure 7b (ii), gates R2, R3 and R4). All of the isolated subsets demonstrated clonal progenitor development into myeloid lineages represented by macrophage, granulocyte and erythroid colonies. 3) . There was no difference in the colony type generated by these populations (data not shown).
The isolation of individual colonies and subsequent PCR analysis for human-specific sequences (CART-1) and the presence or absence of Y-chromosome-specific sequences (DYS14) (Figure 7a ) allowed the quantitation of primitive hematopoietic clonogenic progenitors that arise from male CD34 neg or female CD34 pos -SRC to be examined. Representative PCR of individually isolated colonies for human-and malespecific sequences are shown in Figure 7c . CD34 + , CD34 + CD38 À and CD34 + CD38 + progenitors derived from control mice transplanted with 60 000 male CD34 + Lin À cells alone were positive for both human-and male-specific sequences (Figure 7c(i), lanes 1-9) , whereas mice transplanted with 180 000 female-derived CD34 + Lin À cells gave rise to progenitors that were positive for human sequences but devoid of male Y-chromosome-specific sequences (Figure 7c (ii), lanes 1-9). CART-1 and DYS14 PCR amplification performed on methylcellulose samples devoid of cells did not demonstrate the presence of human or Y-chromosome DNA sequences (data not shown). CD34 + hematopoietic progenitors isolated from mice transplanted with male CD34
À Lin À cells cocultured with female CD34 + Lin À cells demonstrated colonies that expressed both human-and male-specific sequences (Figure 7c(iii), lane 3) , indicating that a proportion of CD34 + progenitors originated from male-derived CD34
À Lin À cells. The converse was also observed; human progenitors lacking male-specific sequences (Figure 7c(iv) ) and it was inferred that 15.4% of the colonies that tested CART-1 positive were derived from the female CD34 neg -SRC. These results provide direct evidence that CD34 neg -SRC can give rise to CD34 + cells that retain the proliferative and differentiative capacity of primitive progenitors.
Hematopoietic progenitors derived from CD34
neg -SRC are detected in the CD34 + CD38 À subfraction
In order to further characterize the cellular development of the CD34 neg -SRC in vivo, human CD34 + cells were further fractioned based on the presence or absence of cell surface CD38 expression (Figure 7b + cells were derived strictly from the female CD34 pos -SRC (Figure 7c(iii), lanes 7-9) . Similar to the data described for CD34 + cell BM-derived progenitors, CD34 + CD38 À cells derived from engrafted mice transplanted (Table 2) . Conversely, Ychromosome sequences were also detected in 90% of the progenitor colonies when male CD34 + Lin À cells were cotransplanted with female CD34
À Lin À cells, suggesting that the frequency of colonies originating from the CD34 neg -SRC arose from the remaining 10% of hematopoietic progenitors ( Table 2) . Analysis of the human CD34 + CD38 + population from the same mice revealed that progenitors were derived from the CD34 pos -SRC exclusively (Table 2 ). These results indicate that the CD34 neg -SRC produced progenitors with a more primitive (CD34 + CD38 À ) phenotype after coculture and transplantation.
Discussion
The identification of human CD34 À Lin À cells with repopulating function has added complexity to our view of the human stem cell compartment, 8, 12 and has driven the need to compare the repopulating capacity of purified CD34
À Lin À vs CD34 + Lin À stem cell counterparts. Gene marking studies provide a method to determine the functional contribution of different repopulating cell types to detectable engraftment in human systems. 7, 26 However, this approach has been limited due to difficulties in attaining efficient marking of human repopulating cells. 7, 26 In this report, we have described the differential repopulating potential of human CD34
À Lin À and CD34 + Lin À repopulating stem cells in the same recipient using cotransplantation of male and female cells into the NOD/SCID EMV null mouse. 5, 7, 19 In effect, this strategy provides starting populations of 'Y-chromosome-marked' cells of a given phenotype that can be tracked in vivo in the presence of other phenotypically distinct stem cell subsets. This approach permits the prospective isolation of candidate stem cell populations and explores the interplay of distinct stem cell populations and their contribution to repopulation without the added complications of inefficient gene marking procedures. À Lin À population. 8, 25 The distinct repopulating characteristics of human CD34
À and CD34 + stem cells when transplanted alone or together support the emerging premise that the human stem cell compartment consists of a heterogeneous array of cellular subsets with varying degrees of stem cell potential. 8, 13 Consequently, it is now critical to integrate the functions of individual stem cell subtypes and the possible interaction between these cells into models for the overall understanding of hematopoietic reconstitution. As illustrated in Figure 8 , we propose a working model of CD34
À and CD34 + cell interaction based on our findings.
In addition to strong intrinsic repopulating capacity, human CD34 + Lin À stem cells also facilitate the repopulating function and maturation of the CD34 neg -SRC enriched within the CD34 À Lin À population. In the presence of CD34 pos -SRC, human CD34 neg -SRC acquired CD34 expression in vivo and the resulting CD34 + and CD34 + CD38 À populations possess multilineage clonogenic progenitor capacity (Figure 8 ). However, the CD34 + progeny arising from the CD34 neg -SRC seem to retain the CD34 + CD38 À phenotype and do not produce detectable CD34 + CD38 + progenitors after 6-10 weeks in vivo. These experiments performed in the NOD/SCID EMV null mouse support the recent discovery that human CD34 expression was reversible in primary and secondary transplanted immunedeficient recipients. 27 The acquisition of CD34 expression by CD34
À Lin À cells has been reported previously. 8 À Lin À population since transplant of cocultured populations into recipients augmented the reconstitution frequency and the production of primitive progeny originating from the CD34 neg -SRC. Accordingly, our present findings together with other studies in the murine system demonstrate Both clinical experience in human transplantation 29 and experimental evidence in mouse models have suggested the existence of two classes of repopulating cells: committed progenitor cells that provide rapid initial engraftment and primitive hematopoietic cells that provide delayed but extended and durable reconstitution. 12, 13, 30 Similar findings have been suggested in human/mouse xenotransplant assays by tracking the in vivo function of individual clones of genetically marked human cells during the reconstitution of NOD/SCID mice. 26 Using proviral integration as genetic tags, Dick's group tracked human SRC and their progeny in vivo and demonstrated that some repopulating stem cell clones contributed to engraftment earlier during the reconstitution process and then were lost, while other clones contributed later. However, the specific nature and phenotype of the human cells responsible for these stages of repopulating function was not elucidated since these distinctly functioning SRCs were not prospectively isolated. 25 Here, we investigated the relation between CD34
À and CD34 Cotransplant of CD34 + and CD34 À stem cells DA Hess et al derived from the male CD34 neg -SRCs. Consistent with delayed maturation processes, in vivo progenitors originating from the CD34 neg -SRC were identified exclusively within the CD34 + CD38
À population, and CD34 neg -SRC did not give rise to more mature CD34 + CD38 + cells. We propose that the low levels of engraftment associated with human CD34 neg -SRC observed in this model system may be due to limited differentiative potential towards committed progenitors in comparison to the more robust differentiation and proliferation of CD34 pos -SRC. This is consistent with the premise that the CD34 neg -SRC represents a dormant subset of human repopulating cells similar to its murine counterpart.
The rational design of clinical protocols using purified stem cell populations is currently based solely on CD34 + hematopoietic cells. 3, [31] [32] [33] However, our studies indicate that lineagedepleted (Lin À ) CD34 + and CD34 À cells possess repopulating capacity and are functionally related components of the human stem cell compartment. These data strengthen an emerging functional relationship between CD34 À and CD34 + stem cells, with both populations contributing towards hematopoietic reconstitution. 11, 13 We suggest that further understanding of the dynamic nature and interactions among primitive cells comprising the hematopoietic stem cell compartment will lead to optimal selection of purified stem cells and enhanced reconstitution during clinical hematopoietic reconstitution. 
Figure 8
Proposed model of the functional interaction between human CD34 + and CD34 À repopulating cells.
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